Category Archives: Biotechnology

The American Soybean Association (ASA) submitted comments this week to both the U.S. Department of Agriculture (USDA) and the U.S. Food and Drug Administration (FDA) regarding regulations in response to advances in genetic engineering. ASA included in comments to USDA, that biotechnology is an essential tool in farmers quest to produce enough food to meet the needs of 9.7 billion people by 2050, creating the need for a clear, science-based regulatory system in the U.S. as an example and standard for regulatory systems of biotechnology internationally. While applauding USDAs efforts to reduce the burden on regulated entities, ASA expressed concern that aspects of the rule as proposed will increase the regulatory burden and stifle research and innovation. Additionally, ASAs comments to FDA cheered USDAs proposal to exclude certain genome-editing techniques from requiring pre-market approvals because they are low risk and could be found in nature or achieved through traditional breeding methods. ASA concluded its support saying, Technological advancements such as genome editing offer an additional tool to combat threats while also improving sustainability in production agriculture. Full comments to USDA and FDA can be found here and here, respectively. See the original post here: ASA Provides Input to USDA, FDA … Continue reading →

SAN ANTONIO, TEXAS--(Marketwired - June 15, 2017) - Nerium Biotechnology, Inc. ("Nerium" or the "Company") today announces that it is mailing a letter to shareholders in advance of the Company's annual meeting on June 29, 2017. The shareholder letter which is reproduced below, provides important information for shareholder consideration regarding the election of directors at the annual meeting. This is an important meeting for shareholders as the decisions made with respect to the election of the Company's board of directors will determine Nerium's future. Nerium is pleased to confirm the support of its largest shareholders for the re-election of the current board of directors (the "Board"). The shareholder letter, as well as a letter received by Nerium from Crandell Addington, a large shareholder of Nerium and CEO, Chairman and Director of Phoenix Biotechnology, will be mailed to shareholders today. A copy of the shareholder letter and other materials is available on the Company's issuer profile on SEDAR and on the Company's website http://www.nbiinvestors.com. Your Board needs your support, please vote using only the GREEN proxy FOR Dennis R. Knocke, Gustavo A. Ulloa, Jr., Richard J.G. Boxer, Michael Burke, Kerry Mitchell and Peter A. Leininger, M.D. Shareholders are encouraged to vote … Continue reading →

(CALIFORNIA) Thebirthplace of biotechnology is to receive$10 million for a pioneering precision medicine programme. It was announced this week thatthe California Initiative to Advance Precision Medicine (CIAPM) has been awarded the money from the local governments budget, a decision welcomed by theCalifornia Life Sciences Association (CLSA). Sara Radcliffe, President & CEO, CLSA, said:California Life Sciences Association (CLSA) applauds Governor Jerry Brown, California State Senate and California Assembly leaders for their strong support of life sciences innovation, as demonstrated again in this years 2017-2018 budget deal which allocates a $10 million investment in precision medicine research. California is the birthplace of biotechnology and today the states life sciences sector employs over 287,200 people working to develop innovative new medicines, technologies and therapies needed to treat and cure patients. The Californian city of San Diego ishostingtheBIO International Conventionalthe global event for biotechnology next week. It will celebrate the industrys many breakthroughs and on going impact on society.It will take place at the San Diego Convention Center between 19 and 22 June. BIO International ConventionalCalifornia Initiative to Advance Precision Medicine See the rest here: $10M for birthplace of biotechnology - Innovators Magazine … Continue reading →

An internationally renowned biotechnology scientist, Professor Rocky Tuan Sung-chi, has been recommended to succeed Joseph Sung Jao-yiu as Chinese University vice-chancellor. Born in Hong Kong and educated in the United States, Tuan is currently working at the University of Pittsburgh as director of the institutions cellular and molecular engineering lab, executive vice-chairman of the Department of Orthopaedic Surgery and a professor in the Department of Bioengineering. He has been serving as a distinguished visiting professor and director of the Institute for Tissue Engineering and Regenerative Medicine at Chinese University. The institutions council said on Thursday that it would recommend Tuan to be the next vice-chancellor. It will hold a consultation of up to six weeks with staff, students and alumni, but the universitys teachers association vowed to boycott it, saying the council had fooled it by saying it was not sure who the candidate was. In May 2016, Tuan was one of the 10 Carnegie Science Award winners for his extensive experience in applying adult stem cells for tissue engineering and regenerative medicine. Hes a good scientist, professionally speaking, with a major interest in bone and tendon regeneration, Professor Chan Wai-yee of the universitys School of Biomedical Sciences said. He … Continue reading →

As a group of visiting scientists prepared to board a plane in Hawaii that would take them back home to China, U.S. customs agents found rice seeds in their luggage. Those seeds are likely to land at least one scientist in federal prison. Agriculture today is a high-tech business, but as that technology has developed, so has the temptation to take shortcuts and steal trade secrets that could unlock huge profits. The FBI calls agricultural economic espionage a growing threat and some are worried that biotech piracy can spell big trouble for a dynamic and growing U.S. industry. Had they succeeded in stealing the gene-spliced rice, the scientists may have been able to reverse-engineer it and ultimately undercut [US company] Ventrias market. [Ventria President and CEO Scott] Deeter says it could have driven his company out of business. Where the commodity in question is grown in open fields, its sometimes difficult, [Jason] Griess [the assistant U.S. attorney for the Southern District of Iowa] says. Theft of intellectual property costs the U.S. economy hundreds of billions of dollars each year, according to a recent report from the Commission on the Theft of American Intellectual Property, a Washington, D.C.-based ad-hoc panel formed … Continue reading →

Ira Pastor, CEO of Bioquark, a Philadelphia-based biotechnology company, believes we will on day be able to reset the brain of patients declared brain-dead using a series of stem cell injections and nerve stimulations. Until recently, death was medically defined as a loss of heart and lung function but as medical technology has advanced so has the qualifications. Now, since both heartbeat and breathing functions can be performed for a patient by machine, death is almost universally declared when there is a loss of activity in the brain stem. However, Pastor does think that this loss of brain function is as irreversible as weve come expect. Initially, Bioquark was slated to start trials for the procedure last year in India but, due to strong opposition by the Indian Council of Medical Research, those studies were canceled. Nevertheless, Ira Pastor and his collaborator Himanshu Bansal, an orthopedic surgeon, remain undaunted and have announced a new series of test to happen soon in a nameless South American country. Although they have not released the details of the revolutionary procedure, we can gather a general idea of their plan to reanimate the brain-dead from the papers regarding their original canceled trial. Originally, the … Continue reading →

Lexington Herald Leader Biotechnology company opens mosquito factory in Lexington ... Lexington Herald Leader A Lexington biotechnology company aimed at fighting mosquito-borne diseases such as the Zika virus opened a mosquito factory Friday on Malabu Drive. and more » Go here to read the rest: Biotechnology company opens mosquito factory in Lexington ... - Lexington Herald Leader … Continue reading →

NormanObserver.com Puma Biotechnology Inc (PBYI) Price Target Raised to $60.00 The Cerbat Gem Puma Biotechnology Inc (NYSE:PBYI) had its price objective increased by Royal Bank Of Canada from $40.00 to $60.00 in a research note published on Thursday, May 25th, MarketBeat Ratings reports. Royal Bank Of Canada currently has a sector perform ... Right After Earnings, The Intelligent Options Trade in Puma Biotechnology IncCML News Puma Biotechnology's (PBYI) Buy Rating Reaffirmed at Stifel NicolausSports Perspectives The Puma Biotechnology Inc (PBYI) Downgraded by Zacks Investment Research to HoldBangaloreWeekly Markets Daily -Transcript Daily -Chaffey Breeze -SEC.gov all 94 news articles » Here is the original post: Puma Biotechnology Inc (PBYI) Price Target Raised to $60.00 - The Cerbat Gem … Continue reading →

1. What is Agricultural Biotechnology? Agricultural biotechnology is a range of tools, including traditional breeding techniques, that alter living organisms, or parts of organisms, to make or modify products; improve plants or animals; or develop microorganisms for specific agricultural uses. Modern biotechnology today includes the tools of genetic engineering. 2. How is Agricultural Biotechnology being used? Biotechnology provides farmers with tools that can make production cheaper and more manageable. For example, some biotechnology crops can be engineered to tolerate specific herbicides, which make weed control simpler and more efficient. Other crops have been engineered to be resistant to specific plant diseases and insect pests, which can make pest control more reliable and effective, and/or can decrease the use of synthetic pesticides. These crop production options can help countries keep pace with demands for food while reducing production costs. A number of biotechnology-derived crops that have been deregulated by the USDA and reviewed for food safety by the Food and Drug Administration (FDA) and/or the Environmental Protection Agency (EPA) have been adopted by growers. Many other types of crops are now in the research and development stages. While it is not possible to know exactly which will come to fruition, certainly … Continue reading →

iShares Nasdaq Biotechnology Index Fund (IBB) Shares Sold by Neumann Capital Management LLC The Cerbat Gem iShares Nasdaq Biotechnology Index Fund logo Neumann Capital Management LLC lowered its position in shares of iShares Nasdaq Biotechnology Index Fund (NASDAQ:IBB) by 44.8% during the first quarter, according to its most recent Form 13F filing with ... The iShares NASDAQ Biotechnology Index (IBB) Position Boosted by Stratos Wealth Partners LTD.BangaloreWeekly Glassman Wealth Services Has $352000 Position in iShares Nasdaq Biotechnology Index Fund (IBB)Chaffey Breeze iShares Nasdaq Biotechnology Index Fund (IBB) Stake Raised by Private Management Group Inc.Stock Observer all 10 news articles » The rest is here: iShares Nasdaq Biotechnology Index Fund (IBB) Shares Sold by Neumann Capital Management LLC - The Cerbat Gem … Continue reading →